Mascaux, Céline
Angelova, Mihaela
Vasaturo, Angela
Beane, Jennifer
Hijazi, Kahkeshan
Anthoine, Geraldine
Buttard, Bénédicte
Rothe, Françoise
Willard-Gallo, Karen
Haller, Annick
Ninane, Vincent
Burny, Arsène
Sculier, Jean-Paul
Spira, Avi
Galon, Jérôme
Article History
Received: 27 November 2018
Accepted: 24 May 2019
First Online: 26 June 2019
Competing interests
: The authors declare competing financial interests: J.G. is co-founder of HalioDx biotech company. A.S. is an employee of Johnson and Johnson. C.M. received honoraria for expertise and speaker roles, being on the advisory board or attending meetings, from Boehringher Ingelheim, Lilly, Bristol-Myers Squibb, AstraZeneca, Roche, Kephren and Novartis. European Patent Application EP19305434.3 was filed on 2 April 2019 by Inserm, Université Paris Descartes, Université Paris Diderot, Sorbonne Université, Université Aix-Marseille, APHM and Université Libre de Bruxelles, and European Patent Application EP19305535.7 was filed on 26 April 2019 by Inserm, Université Paris Descartes, Université Paris Diderot, Sorbonne Université, Université Aix-Marseille, APHM and Université Libre de Bruxelles. The inventors designation is in progress.